(Q37861634)

24 August 2017

1 reference

title

Human papillomavirus vaccine: widening the scope for cancer prevention (English)

1 reference

24 August 2017

1 reference

Jae Hong No

1

1 reference

24 August 2017

Mi-Kyung Kim

2

1 reference

24 August 2017

Yong-Tark Jeon

3

1 reference

24 August 2017

Yong-Beom Kim

4

1 reference

24 August 2017

Yong-Sang Song

5

1 reference

24 August 2017

publication date

1 April 2011

1 reference

24 August 2017

published in

Molecular Carcinogenesis

1 reference

24 August 2017

volume

50

1 reference

24 August 2017

issue

4

1 reference

24 August 2017

page(s)

244-253

1 reference

Global cancer statistics, 2002

24 August 2017

cites work

1 reference

Chapter 2: The burden of HPV-related cancers

21 January 2018

1 reference

Assessing the annual economic burden of preventing and treating anogenital human papillomavirus-related disease in the US: analytic framework and review of the literature

21 January 2018

1 reference

Epidemiologic classification of human papillomavirus types associated with cervical cancer

21 January 2018

1 reference

Persistent human papillomavirus infection and cervical neoplasia: a systematic review and meta-analysis

21 January 2018

1 reference

Comparison of human papillomavirus types 16, 18, and 6 capsid antibody responses following incident infection

21 January 2018

1 reference

Immune concept of human papillomaviruses and related antigens in local cancer milieu of human cervical neoplasia

21 January 2018

1 reference

Prevalence of HPV infection among females in the United States

21 January 2018

1 reference

Worldwide prevalence and genotype distribution of cervical human papillomavirus DNA in women with normal cytology: a meta-analysis

21 January 2018

1 reference

Sexual behaviour and HPV infections in 18 to 29 year old women in the pre-vaccine era in the Netherlands

21 January 2018

1 reference

Age-specific prevalence of infection with human papillomavirus in females: a global review

21 January 2018

1 reference

Human papillomavirus, smoking, and sexual practices in the etiology of anal cancer

21 January 2018

1 reference

Increased risk of high-grade anal neoplasia associated with a human papillomavirus type 16 E6 sequence variant

21 January 2018

1 reference

Prevalence and type distribution of human papillomavirus in carcinoma and intraepithelial neoplasia of the vulva, vagina and anus: a meta-analysis

21 January 2018

1 reference

Case-control study of human papillomavirus and oropharyngeal cancer

21 January 2018

1 reference

Incidence of human papillomavirus (HPV) positive tonsillar carcinoma in Stockholm, Sweden: an epidemic of viral-induced carcinoma?

21 January 2018

1 reference

Prevention of cervical cancer through papillomavirus vaccination

21 January 2018

1 reference

Basic mechanisms of high-risk human papillomavirus-induced carcinogenesis: roles of E6 and E7 proteins

21 January 2018

1 reference

Regulation of Notch1 gene expression by p53 in epithelial cells

21 January 2018

1 reference

Identification of a novel telomerase repressor that interacts with the human papillomavirus type-16 E6/E6-AP complex

21 January 2018

1 reference

Human papillomavirus type 18 E6 protein binds the cellular PDZ protein TIP-2/GIPC, which is involved in transforming growth factor beta signaling and triggers its degradation by the proteasome

21 January 2018

1 reference

Human papillomavirus 16 E6 oncoprotein interferences with insulin signaling pathway by binding to tuberin

21 January 2018

1 reference

Structure of the human Papillomavirus E7 oncoprotein and its mechanism for inactivation of the retinoblastoma tumor suppressor

21 January 2018

1 reference

Human papillomavirus 16 E5 up-regulates the expression of vascular endothelial growth factor through the activation of epidermal growth factor receptor, MEK/ ERK1,2 and PI3K/Akt

21 January 2018

1 reference

Immune evasion in human papillomavirus-associated cervical cancer

21 January 2018

1 reference

Enhanced humoral and memory B cellular immunity using HPV16/18 L1 VLP vaccine formulated with the MPL/aluminium salt combination (AS04) compared to aluminium salt only

21 January 2018

1 reference

Sustained efficacy and immunogenicity of the human papillomavirus (HPV)-16/18 AS04-adjuvanted vaccine: analysis of a randomised placebo-controlled trial up to 6.4 years

21 January 2018

1 reference

Long-term persistence of anti-HPV-16 and -18 antibodies induced by vaccination with the AS04-adjuvanted cervical cancer vaccine: modeling of sustained antibody responses

21 January 2018

1 reference

Induction of immune memory following administration of a prophylactic quadrivalent human papillomavirus (HPV) types 6/11/16/18 L1 virus-like particle (VLP) vaccine

21 January 2018

1 reference

An update of prophylactic human papillomavirus L1 virus-like particle vaccine clinical trial results

21 January 2018

1 reference

Quadrivalent vaccine against human papillomavirus to prevent anogenital diseases

21 January 2018

1 reference

Quadrivalent vaccine against human papillomavirus to prevent high-grade cervical lesions

21 January 2018

1 reference

Efficacy of human papillomavirus (HPV)-16/18 AS04-adjuvanted vaccine against cervical infection and precancer caused by oncogenic HPV types (PATRICIA): final analysis of a double-blind, randomised study in young women

21 January 2018

1 reference

Human papillomavirus vaccines and the potential for cross-protection between related HPV types

21 January 2018

1 reference

Sustained efficacy up to 4.5 years of a bivalent L1 virus-like particle vaccine against human papillomavirus types 16 and 18: follow-up from a randomised control trial

21 January 2018

1 reference

Antibodies from women immunized with Gardasil cross-neutralize HPV 45 pseudovirions

21 January 2018

1 reference

The epidemiology of genital human papillomavirus infection

21 January 2018

1 reference

Epidemiology of Genital Human Papillomavirus Infection

21 January 2018

1 reference

A prospective study of age trends in cervical human papillomavirus acquisition and persistence in Guanacaste, Costa Rica

21 January 2018

1 reference

Prevalence of HPV infection among men: A systematic review of the literature.

21 January 2018

1 reference

The optimal anatomic sites for sampling heterosexual men for human papillomavirus (HPV) detection: the HPV detection in men study

21 January 2018

1 reference

Condom use and other factors affecting penile human papillomavirus detection in men attending a sexually transmitted disease clinic

21 January 2018

1 reference

Modeling the sexual transmissibility of human papillomavirus infection using stochastic computer simulation and empirical data from a cohort study of young women in Montreal, Canada

21 January 2018

1 reference

The theoretical population-level impact of a prophylactic human papilloma virus vaccine

21 January 2018

1 reference

Human papillomavirus vaccination in the United Kingdom: what about boys?

21 January 2018

1 reference

Model for assessing human papillomavirus vaccination strategies

21 January 2018

1 reference

The value of including boys in an HPV vaccination programme: a cost-effectiveness analysis in a low-resource setting

21 January 2018

1 reference

Human papillomavirus vaccine acceptability among young adult men.

21 January 2018

1 reference

Immunogenicity and safety of human papillomavirus (HPV)-16/18 AS04-adjuvanted vaccine in healthy boys aged 10-18 years

21 January 2018

1 reference

Cancer risk following organ transplantation: a nationwide cohort study in Sweden

21 January 2018

1 reference

Chapter 16: HPV vaccines in immunocompromised women and men.

21 January 2018

1 reference

Hepatitis A and B immunizations of individuals infected with human immunodeficiency virus

21 January 2018

1 reference

Prevention of cervical cancer in women with HIV.

21 January 2018

1 reference

Adherence to cervical screening in the era of human papillomavirus vaccination: how low is too low?

21 January 2018

1 reference

The current and future role of screening in the era of HPV vaccination

21 January 2018

1 reference

Chapter 1: HPV in the etiology of human cancer

21 January 2018

1 reference

Determinants of Prevalence, Acquisition, and Persistence of Human Papillomavirus in Healthy Mexican Military Men

21 January 2018

1 reference

A 2‐Year Prospective Study of Human Papillomavirus Persistence among Women with a Cytological Diagnosis of Atypical Squamous Cells of Undetermined Significance or Low‐Grade Squamous Intraepithelial Lesion

21 January 2018

1 reference

21 January 2018

Identifiers

DOI

10.1002/MC.20657

1 reference

release_yozoatwxgjfqzbxwomnhcw3emi

24 August 2017

Fatcat ID

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/yozoatwxgjfqzbxwomnhcw3emi

mapped directly with Wikidata item

24 November 2022

based on heuristic

1 reference